2m 2m 2m 2m 2m 2m 2m
BEAM THERAPEUTIC (BEAM)
NASDAQ
$33.30+$0.09 (+0.29%)
Price as of Jun 23, 2026 7:59 PM EDT- $3.7BMarket Cap
- 112.63%1-Year Change
- BiotechnologyIndustry
BEAM THERAPEUTIC (BEAM)
$33.30+$0.09 (+0.29%)
BEAM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $33.20 | ||
Change | +$1.39 (+4.07%) | ||
Open | $35.26 | ||
High | $36.67 | ||
Low | $32.79 | ||
Previous Close | $35.53 | ||
Volume | 3,604,536 | ||
30-Day Average Volume | 2,073,815 | ||
1-Week Change | 14.17% | ||
1-Month Change | 24.06% | ||
1-Year Change | 112.63% | ||
3-Year Change | 9.22% | ||
5-Year Change | -58.68% | ||
Fundamentals | |||
Shares Outstanding | 102.9M | ||
Total Assets | $1.5B | ||
Market Cap | $3.7B | ||
Enterprise Value | $3.5B | ||
Period: QTR TTM FY | |||
Revenue | $31.7M | ||
Net Income | -$94.3M | ||
Free Cash Flow | -$130.7M | ||
EBIT | -$93.3M | ||
EBITDA | -$87.7M | ||
Net Working Capital | $1.2B | ||
EPS | -$0.91 | ||
Enterprise Value/EBITDA | -40 | ||
Enterprise Value/Revenue | 109 | ||
P/B | 3 | ||
P/E | -39 | ||
PEG | 0 | ||
Price/Free Cash Flow | -28 | ||
Price/Operating Cash Flow | -28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 02/04/2014 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue